Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer

NCT06548919 · clinicaltrials.gov ↗

RECRUITING

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

ESR1 Gene Mutation
Advanced Breast Cancer

Interventions

DRUG: Endocrine therapy
DRUG: Chemotherapy Prednisone

Sponsor

SciClone Pharmaceuticals